FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,208 | -88.3% | 101,985 | -73.8% | 0.00% | -85.7% |
| Q2 2023 | $1,849,508 | -0.0% | 388,552 | +19.7% | 0.01% | -74.1% |
| Q1 2023 | $1,849,690 | +292.5% | 324,507 | +594.8% | 0.03% | +200.0% |
| Q4 2022 | $471,253 | +12.5% | 46,705 | +149.8% | 0.01% | +12.5% |
| Q3 2022 | $419,000 | -60.2% | 18,700 | -31.2% | 0.01% | -71.4% |
| Q1 2022 | $1,054,000 | +294.8% | 27,175 | +503.2% | 0.03% | +250.0% |
| Q3 2021 | $267,000 | -65.1% | 4,505 | -46.4% | 0.01% | -84.3% |
| Q4 2020 | $765,000 | – | 8,410 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |